Paediatric asthma
Loading...
Date
Authors
Green, Robin J.
Outhoff, Kim
Journal Title
Journal ISSN
Volume Title
Publisher
Medpharm Publications
Abstract
Childhood asthma has been with us for many years, and prevalence has been increasing. Asthma is the fifth most common killer in our
country, and although it may not kill as many people as infectious diseases, the quality of life of an asthmatic may be seriously impaired,
leaving a child or adult with compromised lung health that never goes away. The diagnosis of asthma, which is characterised by variable
expiratory airflow limitation, is primarily based on recurrent cough and wheeze. Asthma management should be personalised, and longterm
asthma management involves assessing, adjusting and reviewing treatment response. Medication should be titrated up or down for
individual patient needs.
Description
Keywords
Paediatric asthma, Inhaled corticosteroids, Long-acting beta2-agonist (LABA), Short-acting beta2-agonist (SABA)
Sustainable Development Goals
Citation
Green, R. & Outhoff, K. 2022, 'Paediatric asthma', SA Pharmaceutical Journal, vol. 89, no. 4, pp. 12-14.